Tag:

biomarker deals

Latest Headlines

Latest Headlines

Regulus sets off whirlwind of activity

In a busy week, Regulus Therapeutics signed a microRNA biomarker pact with Biogen Idec ($BIIB), announced an miRNA therapeutics deal with AstraZeneca ($AZN) and filed an IPO of $57.5 million.

Pfizer, Exonhit partner on Alzheimer's biomarkers

Paris-based biotech Exonhit Therapeutics has established a research pact with Pfizer to discover Alzheimer's disease biomarkers via a pilot study. The study will use Exonhit's Genome-Wide SpliceArray

Drug giant Merck, biotech giant BGI team up to discover biomarkers

BGI will take all that sequencing power it possesses as the world's largest genomics center--the same power that helped crack the German E. coli case--and put it together with Merck ($MRK), one of

Protagen, Biogen Idec partner on MS biomarkers

BioArray News reports on Dortmund, Germany-based Protagen's continuing mission to partner with other companies on biomarker discovery. The latest is a deal with Biogen Idec to discover biomarkers for

Caliper, HistoRx get together for imaging, analysis

Caliper Life Sciences and HistoRx are pooling their resources to produce a new way of imaging and analyzing tissue to measure proteins based on immuno-fluorescence. According to a release, the

Nuclea, Boston Medical team up to find cancer biomarkers

Nuclea Biotechnologies, based in Pittsfield, MA, is partnering with the Boston Medical Center to research and develop biomarkers for patients with breast and prostate cancers. Under the partnership,